Stay updated on Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.

Latest updates to the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe history adds Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedA new revision entry 'Revision: v3.3.2' was added and the previous 'Revision: v3.2.0' was removed, indicating an administrative update to the page's revision history.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page no longer shows the government funding/operating status banner, with no impact on trial data or records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedThe new version updates the Study Status and Contacts/Locations sections, including changes to recruitment status and the addition of trial sites.SummaryDifference0.1%

- Check83 days agoChange DetectedUpdated core content with new study status and contacts/locations dated 2025-10-09/2025-10-08, replacing the prior 2025-09-16 entry.SummaryDifference0.8%

- Check90 days agoChange DetectedSummary: The page adds a government-operating-status notice and new version tag (v3.2.0) while removing the old version tag (v3.1.0). This signals an update to the page’s operating status information and the release version.SummaryDifference11%

Stay in the know with updates to Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.